Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-31

Clinical Trial Update: A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing pharmacokinetics of ethinyl estradiol between NuvaRing contraceptive patch and a combined oral contraceptive in healthy female subjects;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microgynon 30 (ethinyl estradiol / levonorgestrel)
  • Nuvaring (etonogestrel and ethinyl estradiol)

Snippet

Sponsor: Organon and Co | Conditions: Contraception | Phase 4 | Status: COMPLETED | Results posted: 2010-03-31